STAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug

Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on marketing plans for a Duchenne muscular dystrophy treatment, and refusing to fix a pricing glitch that was belatedly discovered in their exclusive distribution agreement.

A key issue is a “fatal flaw” in a pricing formula that would make it “economically impracticable” for the therapy to reach patients covered by Medicare, Medicaid, and private insurers, according to a lawsuit filed in a New Jersey state court on Thursday. Nippon Shinyaku and NS Pharma, the subsidiary, disclosed the problem in March 2025.

Basically, the formula ties Medicare reimbursement to the price that Capricor would charge NS Pharma, since it would be the only U.S. buyer. But as it stands, the lawsuit indicated that health care providers would get reimbursed less than they would pay to cover the cost of acquiring and administering the medicine, which is called deramiocel.

Continue to STAT+ to read the full story…

Here’s what you need to know about the cruise ship hantavirus outbreak

MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand what’s coming next. You can read more from the series here.

Eight passengers aboard a Dutch-flagged cruise ship have contracted a type of hantavirus, a rare virus transmitted by rats. Three of them have died. As the ship prepares to dock in the Canary Islands, plans are being finalized to let the remaining passengers and crew disembark safely.

The virus in question appears to have a high fatality rate. Read on for answers to the big questions surrounding the outbreak—and to hear why health experts don’t expect a rerun of the covid-19 pandemic.

What is hantavirus?

Hantaviruses are a group of viruses that typically infect rodents but can be transmitted to humans through exposure to the animals or their droppings, urine, or saliva. The viruses don’t seem to cause illness in rodents, but they can make people very unwell. The symptoms can depend on the type of hantavirus a person has been exposed to. Varieties found in the Americas can cause hantavirus cardiopulmonary syndrome, which affects the lungs and heart and has a fatality rate of up to 50%.

That condition made headlines last year when it caused the death of pianist Betsy Arakawa, the wife of actor Gene Hackman

How many cases have there been so far?

On April 6, a man aboard the MV Hondius developed respiratory symptoms. He became very unwell and died just five days later. His wife, who left the ship at the island of Saint Helena, also developed symptoms. Her health deteriorated during a flight to Johannesburg, South Africa, and she died the following day, on April 26. South Africa’s National Institute of Communicable Diseases tested samples taken from the woman and confirmed that she had hantavirus.

A third person aboard the ship, who developed symptoms on April 28, died on May 2. Four other passengers who became ill were evacuated—one to South Africa and three to the Netherlands.

An eighth person had disembarked in Saint Helena and reported similar symptoms once he was in Zurich, Switzerland. A team at Geneva University Hospitals confirmed that he had become ill from the Andes virus—a form of hantavirus that can be spread between people.

Could this be the start of the next pandemic?

Health experts don’t believe so. They stress that the situation is nothing like the one the coronavirus that causes covid-19 presented in 2020. For a start, the Andes virus is not a mysterious new virus—scientists already have an understanding of it, and Argentina is sharing diagnostic kits it has already developed.

The virus also doesn’t spread in the same way. Officials at the World Health Organization emphasized that the spread of hantavirus requires close contact—the kind a person might have with a partner, household member, or medical caregiver.

The cruise ship outbreak represents “a specific confined setting where people are interacting in a prolonged close contact,” Abdirahman Mahamud, the alert and response director for the WHO’s health emergency program, said at a press event on Thursday. “With the experience our member states have, and the actions they have taken, we believe that this will not lead to a subsequent chain of transmission.”

What about the rest of the people onboard the ship?

All the remaining passengers have been asked to stay in their cabins, which the WHO says are being disinfected. Doctors and health professionals from the WHO and the European Center for Disease Prevention and Control have boarded the ship and are assessing everyone on board.

So far, no one else on board has developed symptoms, Maria Van Kerkhove, WHO acting director for epidemic and pandemic management, said at the press event. That’s “a good sign,” she said, but she added that the Andes virus has a long incubation period (around six weeks). Passengers are being advised to wear a medical mask when they leave their rooms.

At the same event, WHO director general Tedros Adhanom Ghebreyesus said he was in regular contact with the ship’s captain, who was reporting that “morale had increased significantly” since the ship started its journey to the Canary Islands.

What do we know about the Andes virus?

The Andes virus is the only hantavirus that is known to be transmitted between people. That transmission seems to rely on prolonged, intimate contact.

There was an Andes virus outbreak in Argentina around eight years ago. Between November 2018 and February 2019, there were 34 confirmed cases of infection, and 11 deaths. That outbreak was triggered when a person with symptoms attended a social gathering, said Tedros. “We are in a similar situation right now,” he said. “A cluster in a confined space with close contact.”

The fact that the 2018 outbreak was limited to 34 cases should be somewhat reassuring, he implied. “We believe this will be a limited outbreak if the public health measures are implemented and solidarity is shown across all countries,” he said.

How is hantavirus treated?

Unfortunately, we don’t have any specific antiviral treatments or vaccines for hantavirus. The WHO recommends early intensive care for people who develop symptoms. “This can save lives,” Anaïs Legand, WHO technical lead on viral hemorrhagic fevers, said on Thursday.

How did people get infected in the first place?

We don’t yet have an answer to that. But we do know that the couple who died had traveled through Argentina, Chile, and Uruguay on a birdwatching trip before they boarded the ship. That trip included visits to areas where species of rats that carry the Andes virus are known to live. The WHO is working with authorities in Argentina to try to retrace the couple’s movements on that trip.

Has the virus spread beyond the ship?

We don’t yet know for sure. The WHO is receiving reports of “potential suspect cases,” Van Kerkhove said at the Thursday briefing. Some of them have links to the ship or its passengers. Each “alert” will be followed up by health authorities in the relevant country, she said.

Has the US withdrawal from WHO affected anything?

Five US states have said they are monitoring US nationals who have disembarked from the ship. WHO officials are stressing that they are still sharing technical information with the US Centers for Disease Control and Prevention. “Things are … as they used to be,” Tedros said. “WHO’s mission is to help the world to be safe … and we want the American people to be safe as well.”

But it’s worth noting that cuts made by the Trump administration aren’t exactly putting the US in a good position for events like these. Last year, all full-time employees in the CDC’s Vessel Sanitation Program—which helps prevent and control illness outbreaks on cruise ships—were laid off. Further cuts to the CDC have left public health experts worried about how ill prepared the US is to deal with future disease outbreaks.

What will happen next?

Any suspected cases will be monitored by health authorities. Passengers are due to disembark in Tenerife in the Canary Islands on Sunday, May 10, and the WHO has said it will work with the Spanish government to ensure that the risk to residents remains low and that the passengers are treated with dignity and respect.

In the meantime, scientists are working to fully sequence the genome of the virus from patient samples. They want to find out if it is different from the viruses involved in the previous cases. “So far, we haven’t seen anything unusual,” said Van Kerkhove.

Opinion: I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbook

I learned about hantavirus misinformation this week in the same way I now learn about most public health misinformation: My followers sent it to me.

Within hours of the first headlines about a hantavirus outbreak linked to the expedition cruise ship MV Hondius, my DMs started filling with screenshots. One was from the account of a Texas doctor who became well known during Covid for promoting ivermectin. She was already telling followers that ivermectin would work against hantavirus, too.

Read the rest…

<![CDATA[Psilocybin therapy shows fast, lasting relief for depression; clinicians discuss trial hurdles and emerging promise for PTSD and addiction in this podcast.]]>

The Download: AI malaise and babymaking tech

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.

We’ve entered the era of AI malaise

AI is spreading everywhere, and it is not going away. But what will it do? What effect will it have on our society? Will it make life better, or worse? How will we know? What’s the plan?

This technology may very well take our jobs—or just crash the economy instead. Our apps are all getting injections of AI, like it or not. And it is increasingly impossible to tell whether we are relying too much on AI or not using it enough.

We’re all sitting uncomfortably with AI right now. Read our essay on the strange, uncertain mood of the moment.

The era of AI malaise is an essay written by our editor-in-chief Mat Honan. It accompanies MIT Technology Review’s 10 Things That Matter in AI Right Now, our list of the big ideas, trends, and advances in the field that are driving progress today—and will shape what’s possible tomorrow.

Here’s how technology transformed babymaking

Technology is changing the way we make babies. Clinicians have improved hormonal treatments. Embryologists have devised ways to culture embryos in the lab for longer. IVF clinics today offer multiple genetic tests for embryos.

The technology has also had a huge social impact, allowing for changes in the structure of families and providing more reproductive choices for would-be parents. Now, AI and robots are set to usher in another new era for IVF.

Here’s how technology is reshaping babymaking.

—Jessica Hamzelou

This story is from The Checkup, our weekly newsletter giving you the inside track on all things biotech. Sign up to receive it in your inbox every Thursday.

How robots learn: a brief, contemporary history

For decades, researchers have been inspired by science fiction robots that can move through the world, adapt to different environments, and interact with people. But bringing these devices into the messiness of the real world has proved incredibly difficult.

Now, advances in AI are changing that. Instead of relying on rigid rules, robots are learning through trial and error, simulations, and huge amounts of real-world data. The progress represents a revolution in how machines interact with their surroundings.

It also means that Silicon Valley roboticists are dreaming big again. Here’s how we got here. 

—James O’Donnell

This story is from the latest issue of our print magazine, which is all about nature. Subscribe now to read it in full.

The must-reads

I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.

1 ICE plans to develop its own smart glasses
The “ICE Glasses” would identify people in real time. (404 Media)
+ ICE already uses an app with facial recognition to track citizens. (NYT $)
+ A new lawsuit wants to stop ICE using DNA to track critics. (Ars Technica)

2 AI is distorting key economic signals
It makes growth look better and the job market look worse. (WSJ $)
+ Welcome to the economic singularity. (MIT Technology Review)

3 A cyberattack paralyzed thousands of schools
And stole 275 million people’s data from edtech platform Canvas. (NYT $)
+ The digital learning software is used across the US. (CNN)
+ It’s the worst case scenario from an attack on one education platform. (Wired $)

4 The US suspects Nvidia chips were smuggled to Alibaba via Thailand
Super Micro servers containing Nvidia chips were allegedly smuggled. (Bloomberg $)
+ Through a firm linked to Thailand’s national AI initiative. (Reuters $)

5 China’s affordable AI models are increasingly worrying Silicon Valley
They’re often cheaper and more adaptable than US rivals. (Bloomberg $)
+ China is betting big on open source. (MIT Technology Review)

6 Scientists developed a new energy storage system inspired by sunburn
It stores solar energy by mimicking molecular changes in damaged DNA. (BBC)
+ Solar and wind with battery storage are becoming cost-competitive. (Reuters $)
+ Here are three other breakthrough climate technologies. (MIT Technology Review)

7 Russia’s internet crackdown is hobbling small businesses
App restrictions and internet outages are causing headaches. (Reuters $)

8 Younger researchers are more likely to produce “disruptive” science
A new study found more experience led to fewer breakthroughs. (Nature)

9 Why Richard Dawkins was mistaken to believe Claude has feelings
But his line of inquiry wasn’t altogether foolish. (The Atlantic $)
+ Why it’ll be hard to tell if AI ever becomes conscious. (MIT Technology Review)

10 The Golden Globes have new AI rules (and they’re looser than the Oscars’)
AI is permitted as an enhancement, but not as a replacement. (Gizmodo)
+ Last week, the Oscars banned AI actors and writing. (NPR)

Quote of the day

“When I am talking to these astonishing creatures, I totally forget that they are machines. I treat them exactly as I would treat a very intelligent friend.” 

—Evolutionary biologist Richard Dawkins reflects on his interactions with advanced AI systems in an essay published in Unherd.

One More Thing

VIRGINIA HANUSIK


How to stop a state from sinking

In a 10-month span in 2020 and 2021, southwest Louisiana saw five climate-related disasters, including two destructive hurricanes and flash floods. But there could be a better way to protect the area: elevation.

The $6.8 billion Southwest Coastal Louisiana Project is betting that raising buildings while restoring coastal boundary lands that have long acted as natural barriers can preserve this slice of coastline. 

Here’s how officials hope to protect vulnerable communities by lifting homes out of the floodplain.

—Xander Peters

We can still have nice things

A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)

+ Soaking in a hot tub might offer even more health benefits than a sauna.
+ A court has officially protected America’s largest rainforest from future logging.
+ Experience the majesty of the world’s largest owl collection through these intimate, high-detail portraits.
+ A dad has turned his toddler’s random stories into high-production pop songs that are surprisingly catchy.

Two-year longitudinal neuropsychological monitoring after unilateral and staged bilateral subthalamic nucleus deep brain stimulation

IntroductionDeep brain stimulation (DBS) is an increasingly popular therapeutic method for treating motor symptoms in Parkinson’s disease, but its impact on non-motor symptoms in long-term follow-up remains debated.MethodThe primary objective of this study was to monitor the cognitive functioning, mood, and quality of life in 2 years of unilateral and staged bilateral subthalamic nucleus DBS. A cohort of 30 patients was evaluated at three intervals: before DBS surgery, at 6 months, and 24 months post-surgery. The time points of neuropsychological assessments were set to control the impact of unilateral and bilateral DBS throughout the treatment. Two selected groups, unilateral and bilateral DBS, were also analyzed. The study employed a combination of computerized and paper-based tests to assess cognitive functions, alongside questionnaires to gauge emotional state and quality of life. The cognitive evaluation focused on three domains critical for daily activities: attention and processing speed, learning and episodic memory, and executive functions, including working memory and cognitive flexibility.ResultsAnalysis of the entire cohort from baseline through the two follow-up assessments revealed no decline in cognitive function, mood, or quality of life, alongside significant motor improvement. Additional analyses of the two subgroups—unilateral DBS and staged bilateral DBS—also showed no overall decline in any assessed domain over the 2-year follow-up period. However, comparison of cognitive outcomes with normative data indicated a higher proportion of patients meeting criteria for cognitive decline at the 24-month follow-up in the staged bilateral DBS group compared with the unilateral DBS group.ConclusionThe findings support the long-term overall stability of cognitive function, mood, and quality of life following unilateral and staged bilateral subthalamic DBS. Subgroup analyses did not reveal any significant decline in cognitive measures over time. Nevertheless, individual comparisons with normative data showed a higher proportion of patients with memory deficits in the staged bilateral DBS group after the two-year follow-up.

Sleep and circadian rhythm disruptions in animal models of temporal lobe epilepsy

Temporal lobe epilepsy (TLE) is frequently accompanied by disruptions to sleep and circadian rhythms, which substantially contribute to disease burden. Human studies are often confounded by antiseizure medications, limiting insight into underlying mechanisms. Animal models therefore provide critical opportunities to examine causal interactions, yet their translational validity has not been systematically evaluated. In this review, we first outline the relevance of rodent models for studying epilepsy- and sleep-related processes. We then examine current evidence for sleep and circadian disturbances across three commonly used TLE models: the pilocarpine (PILO) model, the kainic acid (KA) model, and the traumatic brain injury (TBI) model. We summarize circadian patterns of seizure occurrence, alterations in sleep–wake architecture, and changes in core circadian clock gene expression, as well as alterations in subcortical brain regions involved in sleep–wake regulation. Across models, sleep is consistently fragmented, and circadian molecular machinery is profoundly disrupted, although the direction and magnitude of changes vary by species, protocol, and epilepsy stage. By comparing findings across animal models and patient studies, this review highlights convergences, discrepancies, and key research gaps. Despite variability, animal models remain indispensable for probing the bidirectional links between epilepsy and sleep–circadian regulation.

Development and validation of machine learning models for predicting functional outcome after low-dose alteplase in the extended time window for acute ischemic stroke

BackgroundThis study aims to develop machine learning (ML) models to predict 90-day functional outcomes for acute ischemic stroke (AIS) patients receiving thrombolysis with low-dose alteplase at 0.6 mg/kg between 4.5 and 9 h after symptom onset.MethodsWe conducted a retrospective analysis of AIS patients receiving thrombolysis between August 1, 2019 and August 31, 2023. Eligible patients were randomly divided into training and validation sets in a 7:3 ratio. Good functional prognosis at 90 days were defined as modified Rankin scale score (mRS) ≤2. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to select optimal features. Five ML algorithms were employed to construct prediction models. Model performance was evaluated using receiver operating characteristic (ROC) curves, area under the curve (AUC) value, decision curve analysis (DCA), and calibration curves. SHapley Additive exPlanations (SHAP) plot was applied to interpret the model predictions.ResultsA total of 202 patients were randomly divided into training (n = 142) and validation (n = 60) sets. The rate of poor functional prognosis at 90 days was 56.34% in the training set and 56.67% in the validation set. Random Forest (RF) model showed the best discriminative ability with the highest AUC of 0.854 in the validation set. Key predictive features included age, baseline systolic blood pressure, white blood cell count, baseline National Institutes of Health Stroke Scale (NIHSS) score, wake-up stroke, the absolute difference volume between the ischemic infarct and the penumbra, intracranial hemorrhage, hemorrhagic transformation classification, and occurrence of pneumonia.ConclusionThe RF-based ML model demonstrated clinical utility for post-intravenous thrombolysis risk stratification by identifying patients at higher risk of poor functional outcomes.

A multichannel MEG time–frequency analysis framework for detecting stage -specific effects of spatial distraction in visual-spatial working memory

IntroductionSpatial distraction can disrupt visual-spatial working memory (VSWM), but its stage-dependent effects on multichannel neural dynamics remain insufficiently characterized. This study presents a multichannel magnetoencephalography (MEG) time—frequency analysis framework to detect stage-specific oscillatory responses to spatial distraction during a VSWM task.MethodsMEG signals were recorded from healthy participants under Distractor and No-distractor conditions and analyzed across encoding, maintenance, and retrieval/decision epochs. Time–frequency power was estimated in the delta, theta, alpha, beta, and gamma bands, and condition differences were evaluated using sensor-level spatiotemporal cluster-based permutation testing and Bonferroni correction within each predefined epoch.ResultsThe proposed analysis revealed a clear stage-specific pattern, with the most prominent modulation occurring during maintenance. Specifically, distraction induced robust and sustained increases in theta-, alpha-, and beta-band power during the retention interval (all cluster-level p < 0.01). Theta activity increased rapidly after maintenance onset and remained elevated throughout the full maintenance period over bilateral temporal, and widespread parieto-occipital sensors, while alpha and beta enhancements also showed temporally continuous and spatially stable patterns across widespread sensor networks.DiscussionThese findings highlight sustained large-scale oscillatory modulation as a key neural signature of distraction during mnemonic maintenance. The study provides an interpretable multichannel signal-analysis perspective on distraction effects in working memory and offers a practical framework for stage-resolved analysis of brain dynamics in cognitive tasks.

Can exercise combined with transcranial direct current stimulation improve cognitive function in older adults? A systematic review and meta-analysis

ObjectiveThis study investigated whether combining exercise with transcranial direct current stimulation (tDCS) improves overall cognition, memory, and executive function in older adults.MethodsFollowing PRISMA guidelines, we systematically searched databases including PubMed, Web of Science, CNKI, and Wan Fang for randomized controlled trials (RCTs) examining the combined effect of exercise and tDCS on cognitive function in older adults. Used RStudio (version 4.2.0) to merge effect sizes and represent them as SMD with a 95% confidence interval (CI). The main effects are synthesized using a random effects model, and heterogeneity sources are explored through subgroup regression and sensitivity analysis.ResultsThe combined exercise and tDCS intervention significantly improved global cognitive function in older adults (SMD = 0.62, 95% CI: 0.36 to 0.89, p < 0.0001). Significant enhancements were observed in executive function (SMD = 0.54, 95% CI: 0.16 to 0.92, p = 0.005) and general cognitive ability (SMD = 0.75, 95% CI: 0.21 to 1.30, p = 0.006), while memory showed a non-significant improvement (SMD = 0.58, 95% CI: −0.03 to 1.19, p = 0.063). Both interventions lasting less than 6 weeks (SMD = 0.94, 95% CI: 0.60 to 1.27, p < 0.0001) and those lasting 6 weeks or longer (SMD = 0.24, 95% CI: 0.10 to 0.37, p = 0.0006) positively impacted cognitive function. However, the effect size was larger for cognitively healthy older adults (SMD = 0.69, 95% CI: 0.20 to 1.18, p = 0.006) compared to those with cognitive impairment (SMD = 0.60, 95% CI: 0.29 to 0.92, p = 0.0002). The combination of tDCS and integrated exercise produced the largest effect size (SMD = 1.74), despite high heterogeneity, while the combination of tDCS and Tai Chi produced the smallest but most robust effect (SMD = 0.25, I 2 = 0%), indicating that exercise type significantly regulates the intervention effect of tDCS (p = 0.0015). Regression analysis shows that tDCS stimulation time has a significant positive regulatory effect on cognitive function in elderly people (p = 0.0002), while the combined intervention period (p = 0.030) and single exercise time (p = 0.034) both have a significant negative regulatory effect.ConclusionBased on limited evidence, we found that a combined intervention of exercise and tDCS is a potentially effective means of improving cognitive function in older adults. However, the extent of improvement varies with the cognitive domain, baseline performance level, and intervention plan.